PEOPLE - NexMed (US) makes appointment:
This article was originally published in Clinica
Executive Summary
NexMed, the US developer of Viratrol, a non-invasive device for treating oral and genital herpes, has appointed Joseph Warusz, previously with Bristol-Myers Squibb, vice-president and chief financial officer.